Goodwill and Intangible Assets

9 Months Ended

Sep. 30, 2020

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill

The following table represents the changes in goodwill by segment:


	D&S East		D&S West		E&C Cryogenics		E&C FinFans		Consolidated
Balance at December 31, 2019	$	117.0	$	118.6	$	176.2	$	399.6	$	811.4
Foreign currency translation adjustments	4.5		—		—		1.3		5.8
Purchase price adjustment	—		—		—		0.4		0.4
Balance at September 30, 2020	$	121.5	$	118.6	$	176.2	$	401.3	$	817.6

We allocated a portion of the D&S West reporting unit’s goodwill to the cryobiological products business asset group on a relative fair value basis. Refer to “Note 2, “Discontinued Operations” for further information. We determined the fair value of D&S West reporting unit as of the goodwill reassignment date to assess whether there was an indication of impairment before the reassignment. We performed an interim goodwill impairment Step 1 test, as defined in our in our Annual Report on Form 10-K for the year ended December 31, 2019, on the D&S West reporting unit prior to the goodwill reassignment and determined that its fair value was substantially in excess of its carrying amount as of September 30, 2020.

Furthermore, when a portion of goodwill is allocated to an asset group to be disposed of, we test the goodwill remaining in the portion of the reporting unit to be retained for impairment. We elected to perform an interim goodwill Step 0 Test, as defined in our in our Annual Report on Form 10-K for the year ended December 31, 2019, on the D&S West reporting unit after the goodwill reassignment. As a result of the Step 0 Test, no impairment of the D&S West reporting unit after the goodwill reassignment was indicated.

Amounts included in accumulated goodwill impairment loss at both September 30, 2020 and December 31, 2019 were $129.0 ($64.4 - D&S West, $40.9 - E&C Cryogenics, $23.7 - E&C FinFans).

Intangible Assets

The following table displays the gross carrying amount and accumulated amortization for finite-lived intangible assets and indefinite-lived intangible assets (exclusive of goodwill) ⁽¹⁾:


		September 30, 2020						December 31, 2019
	Weighted-average Estimated Useful Life	Gross Carrying Amount		Accumulated Amortization		Gross Carrying Amount		Accumulated Amortization
Finite-lived intangible assets:
Customer relationships	13 years	$	382.3	$	(136.4)	$	380.3	$	(115.0)
Unpatented technology	10 years	91.8		(19.6)		90.1		(13.0)
Patents and other	15 years	1.7		(0.4)		20.9		(9.8)
Trademarks and trade names	13 years	2.6		(1.4)		2.4		(1.2)
Land use rights	50 years	10.6		(1.3)		11.0		(1.2)
Total finite-lived intangible assets	13 years	489.0		(159.1)		504.7		(140.2)
Indefinite-lived intangible assets:
Trademarks and trade names		158.8		—		157.9		—
Total intangible assets		$	647.8	$	(159.1)	$	662.6	$	(140.2)

_______________

⁽¹⁾Amounts include the impact of foreign currency translation. Fully amortized or impaired amounts are written off.

Amortization expense for intangible assets subject to amortization was $9.4 and $13.7 for the three months ended September 30, 2020 and 2019, respectively, and $37.3 and $28.2 for the nine months ended September 30, 2020 and 2019, respectively. We estimate amortization expense to be recognized during the next five years as follows:


For the Year Ending December 31,
2020	$	46.7
2021	36.1
2022	36.0
2023	35.7
2024	34.8

Government Grants

We received certain government grants related to land use rights for capacity expansion in China (“China Government Grants”). China Government Grants are generally recorded in other current liabilities and other long-term liabilities in the unaudited condensed consolidated balance sheets and generally recognized into income over the useful life of the associated assets (10 to 50 years).

China Government Grants are presented in our unaudited condensed consolidated balance sheets as follows:


	September 30, 2020		December 31, 2019
Current	$	0.5	$	0.5
Long-term	7.3		7.2
Total China Government Grants	$	7.8	$	7.7